| Symbol | INHSF |
|---|---|
| Name | INHALATION SCIENCES SWEDEN AB |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | SE - 141 5 Sweden Halsovagen 7 |
| Telephone | +46 (0)70 562 5195 |
| Fax | — |
| — | |
| Website | https://www.inhalation.se/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | NOT AVAILABLE |
| Reporting Status | International Reporting: Spotlight Stock Market |
| CIK | — |
| Description | Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Additional info from OTC: |
No news found.